infectious diseases - search results

Prof Colin J Suckling from the University of Strathclyde provides his seasoned opinion on a front-runner antibiotic for the treatment of Clostridium difficile associated diseases.

Professor Colin J Suckling, Research Professor of Chemistry at the Department of Pure & Applied Chemistry, University of Strathclyde looks at how the recent EU Referendum could impact his institution and research. Like many British academics, the result of the recent referendum on the UK’s place in Europe was a...

Chronic diseases account for the vast majority of deaths in European countries. Cardiovascular disease accounts for about 40% of deaths, with about 15% of deaths from ischaemic heart disease, 10% from strokes, and 25% from cancer. If simple lifestyle changes could reduce the risk of chronic disease, people could...

Investigators from the National Institute of Allergy and Infectious Diseases (NIAID) have announced an experimental therapeutic cancer vaccine.

Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.

The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.

A UK study, published in The Lancet Infectious Diseases, found that fully vaccinated people can still catch and transmit the Delta variant of COVID.

Luke Moore is an Infectious Diseases Physician and Clinical Microbiologist in London with special interests in critical care infections, antimicrobial resistance, and healthcare systems.

Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.

SACIDS Africa Centre of Excellence for Infectious Diseases trains young African scientists in research on global health issues: An example of a PhD Student Research on antimicrobial resistance (AMR).

A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.

Koichi Watashi, Senior Researcher from the National Institute of Infectious Diseases, Japan, explores the trick for cell invasion in reaching regulation of hepatitis B entry.

Researchers at the National Institute of Allergy and Infectious Diseases have orchestrated a plan to create a universal influenza vaccine.

Anne Pham-Huy and Antonella Pucci from Immunize Canada discuss the impact of the COVID-19 pandemic on routine vaccinations for children.

Michael Wong, JD, Executive Director at the Physician-Patient Alliance for Health & Safety, posits a combination of quantitative and qualitative assessments of the patient as key measures for tackling sepsis.

With the COVID-19 pandemic behind us, we need to focus on universal vaccines and/or immunotherapeutic strategies and technologies to tackle ongoing endemic infections with SARS-CoV2, influenza, and RSV and prepare for any future pandemics, says Dr Babita Agrawal.

Pewaseskwan actively engages and collaborates with Indigenous communities and relevant stakeholders, including the College of Medicine, the University of Saskatchewan, the Saskatchewan Health Authority and additional collaborators.

In an aim towards battling the global threat of antimicrobial resistance (AMR), the University of Liverpool has been granted £1.3 million to lead the UK Government’s Fleming Fund Fellowship Programme.

Ron Gutman, inventor, serial healthcare and technology entrepreneur, and Stanford University adjunct professor, discusses the emergence of genomic sequencing as a vital tool in mitigating global public health threats.

Scientists from the University of Southampton are on the verge of unveiling a blood test that could uncover millions of undetected tuberculosis (TB) cases.